Day: May 12, 2020

LifeSignals, recently made an announcement that it received the CE Mark for its LifeSignals ECG Remote Monitoring Patch. The patch, integrated with a remote monitoring platform, is designed as continuous electrocardiography (ECG) and heart rate monitor. The ECG Remote Monitoring Patch is disposable and captures data for up to three days. The device is lightweight and splash-proof. Each patch features the company’s patented LC1100 Life Signal Processor, which operates on a coin-cell battery and detects, stores, and securely transmits patient…

VitalConnect announced that it has received FDA Emergency Use Authorization status for use of its VitalPatch to detect changes in the QT interval of hospitalized patients undergoing drug treatment for COVID-19. Hydroxychloroquine and chloroquine, used to treat some COVID-19 patients, are associated with risk of prolonged QT interval that can lead to life-threatening arrhythmias. VitalPatch allows clinicians to remotely and continuously monitor patients at risk of QT prolongation due to COVID-19 treatment. VitalPatch is an FDA-approved device. Besides serving as a…